Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/MEDIJEL GEL

Approved

THERAPEUTIC

MEDIJEL GEL

DDD LTD🇸🇬 Health Sciences Authority

Approval Date: Jun 22, 1990
Approval ID: eb4985fa986c9e91
Company: DDD LTD
Type: Therapeutic

Approval Details

Approval Id: eb4985fa986c9e91
Drug Name: MEDIJEL GEL
Product Name: MEDIJEL GEL
Approval Number: SIN04748P
Approval Date: 1990-06-22
Registrant: INDRUGCO PTE LTD
Licence Holder: INDRUGCO PTE LTD
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: GEL
Route Of Administration: SUBMUCOSAL
Atc Code: A01AD11
Atc Item Name: various
Pharma Manufacturer Name: INDRUGCO PTE LTD
Company Detail Path: /organization/indrugco-pte-ltd

Active Ingredients

LIGNOCAINE HCl

0.66% w/w

AMINACRINE HCl

0.05% w/w

AMINACRINE HCl

0.05% w/w

LIGNOCAINE HCl

0.66% w/w

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 22, 1990

Approval ID

eb4985fa986c9e91

Type

Therapeutic

Back to HSA Approvals

MEDIJEL GEL - HSA Drug Approval Details